Genetics Generation Advancement Corp. (TPEX:4160)
Taiwan · Delayed Price · Currency is TWD 38.90
-0.05 (-0.13%)
Oct 8, 2026, 1:12 PM CST
TPEX:4160 Market Cap
TPEX:4160 has a market cap or net worth of 1.09 billion as of October 9, 2026. It is the 33,260th most valuable company in the world and the 2,013th biggest in Taiwan. Its market cap has decreased by 25.49% in one year.
Market Cap
1.09B
Enterprise Value
897.07M
Revenue
614.42M
Global Rank
Country Rank
#2,013 Taiwan
PE Ratio
60.92
ChartMarket Cap Chart
Since July 15, 2011, TPEX:4160's market cap has increased from 957.80M to 1.09B, an increase of 13.77%. That is a compound annual growth rate of 0.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 1.09B | -18.01% |
| Dec 31, 2025 | 1.33B | -27.41% |
| Dec 31, 2024 | 1.83B | 85.27% |
| Dec 29, 2023 | 988.25M | 48.75% |
| Dec 30, 2022 | 664.37M | 10.48% |
| Dec 30, 2021 | 601.33M | 0.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BIONET | 2.95B |
| DIVA Laboratories | 1.81B |
| Puriblood Medical | 1.06B |
| Kim Forest Enterprise | 815.18M |
| Sofiva Genomics | 720.14M |
| TFBS Bioscience | 665.59M |
| Welgene Biotech | 400.83M |
| Pharmigene | 373.44M |